Director, Hta, Value & Evidence (hv&e), I&i / Brepocitinib (med Rheum)

Pfizer

United States
Base: $176,600.00 to $294,300.00; bonus: 20.0% tar...
Hybrid
Health economic modeling expertise
Cost-effectiveness analysis experience
Real-world evidence study design
This role drives optimal launch and patient access for Brepocitinib by generating robust value and evidence strategies globally

Job Summary

  • This role drives optimal launch and patient access for Brepocitinib by generating robust value and evidence strategies globally.
  • The Director will lead the review of clinical trial outputs to identify HEOR-relevant insights and manage complex HV&E studies including cost-effectiveness models.
  • Candidates are eligible for a performance bonus target of 20.0% of base salary along with comprehensive benefits including 401(k) matching and health coverage.

Matching Summary

This role drives optimal launch and patient access for Brepocitinib by generating robust value and evidence strategies globally.

Salary

Base: $176,600.00 to $294,300.00; Bonus: 20.0% target of base salary; Benefits: 401(k) matching, paid vacation, medical/dental/vision coverage

Skills & Requirements

Must-have

  • Health economic modeling expertise
  • Cost-effectiveness analysis experience
  • Real-world evidence study design
  • Indirect treatment comparisons
  • Global value narrative development
  • Cross-functional matrix collaboration

Nice-to-have

  • HTA organization engagement experience
  • Late-stage asset launch support
  • Inflammation and immunology knowledge
  • Alliance co-development environment
  • Strategic external partnership building

Key Requirements

  • Graduate degree (MSc, MPH, PhD, PharmD)
  • 7+ years experience with MSc/MPH/MBA
  • 5+ years experience with PharmD/PhD in HEOR
  • Permanent work authorization in the United States required
  • No visa sponsorship available for this role

Work Rights

Must have permanent work authorization in the United States

Tailored Resume

Cover Letter